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Abstract
Introduction The purpose of this study was to determine the
incidence, time course, and outcome of acute kidney injury after
major burns and to evaluate the impact of possible predisposing
factors (age, gender, and depth and extent of injury) and the
relation to other dysfunctioning organs and sepsis.
Method We performed an explorative cohort study on patients
with a TBSA% (percentage burned of total body surface area)
of 20% or more who were admitted to a national burn centre.
Acute kidney injury was classified according to the international
consensus classification of RIFLE (Risk, Injury, Failure, Loss of
kidney function, and End-stage kidney disease). Prospectively
collected clinical and laboratory data were used for assessing
organ dysfunction, systemic inflammatory response, and sepsis.
Results The incidence of acute kidney injury among major burns
was 0.11 per 100,000 people per year. Of 127 patients, 31
(24%) developed acute kidney injury (12% Risk, 8% Injury, and
5% Failure). Mean age was 40.6 years (95% confidence interval
[CI] 36.7 to 44.5), TBSA% was 38.6% (95% CI 35.5% to
41.6%), and 25% were women. Mortality was 14% and
increased with increasing RIFLE class (7% normal, 13% Risk,
40% Injury, and 83% Failure). Renal dysfunction occurred within
7 days in 55% of the patients and recovered among all survivors.
Age, TBSA%, and extent of full thickness burns were higher
among the patients who developed acute kidney injury.
Pulmonary dysfunction and systemic inflammatory response
syndrome were present in all of the patients with acute kidney
injury and developed before the acute kidney injury. Sepsis was
a possible aggravating factor in acute kidney injury in 48%.
Extensive deep burns (25% or more full thickness burn)
increased the risk for developing acute kidney injury early (risk
ratio 2.25).
Conclusions Acute kidney injury is common, develops soon
after the burn, and parallels other dysfunctioning organs.
Although acute kidney injury recovered in all survivors, in higher
acute kidney injury groups, together with cardiovascular
dysfunction, it correlated with mortality.
Introduction
Renal failure is a feared complication of critical illness and is
also often an early sign of multiple organ dysfunction, which
complicates the care of critically ill patients [1-4]. In modern
burn care, in which most patients now survive early resuscita-
tion, multiple organ failure is the most common cause of death.
In the largest database of patients with burn injuries, the Amer-
ican Burn Association burn registry, records of the cause of
mortality indicate that 49% of the non-survivors died of organ
failure [5]. The incidence of acute kidney injury (AKI) among
burned patients varied from less than 1% to 36%, depending
on the population studied and the criteria used for
AKI: acute kidney injury; BW: body weight; CI: confidence interval; CT: computed tomography; FiO2: fraction of inspired oxygen; FTB: full thickness 
burn; ICU: intensive care unit; PaO2: arterial partial pressure of oxygen; RIFLE: Risk, Injury, Failure, Loss of kidney function, and End-stage kidney 
disease; SIRS: systemic inflammatory response syndrome; SOFA: sequential organ failure assessment; TBSA%: percentage burned of total body 
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Table 1
Incidence, mortality, and criteria for acute kidney injury in patients with burns
Reference Year Years of study; population AKI AKI mortality Criterion of AKI
Davies, et al. [8] 1979 1958–1979; >1,064 patients 
admitted
28 (<2.6%) 24 (86%) Renal replacement therapy
Davies, et al. [9] 1994 1991; 18 burn units 15 (<1%) 12 (80%) Renal replacement therapy
Leblanc, et al. [10] 1997 1987–1994; 970 patients 
admitted
16 (1.6%) 13 (82%) Renal replacement therapy
Holm, et al. [11] 1999 1994–1998; 328 patients, 
34% TBSA%
48 (15%) 41 (85%) Renal replacement therapy
Tremblay, et al. [12] 2000 1995–1998; 353 patients 
admitted
12 (3.4%) 6 (50%) Renal replacement therapy
Schiavon, et al. [13] 1988 1988; 20 patients, 44% 
TBSA%
4 (20%) 4 (100%) Serum creatinine raised >133 μmol/L above 
value on admission
0 Renal replacement therapy
Saffle, et al. [7] 1993 1987–1990; 529 patients, 
16% TBSA%
50 (10%) 23 (46%) Thermal Injury Organ Failure Score (moderate: 
serum creatinine >222 μmol/L)
4 (0.8%) 4 (100%) Renal replacement therapy
Sheridan, et al. [14] 1998 1989–1994; 56 patients who 
died
37 (68%) - Serum BUN ≥100 and creatinine ≥3.5 or urine 
output ≤500 mL/day
Jeschke, et al. [15] 1998 1966–1997; 5,000 children 
admitted
60 (1.2%) 44 (73%) Oliguria (<0.5 mL/kg per hour for >36 hours), 
serum urea nitrogen/creatinine ratio <20, serum 
creatinine >177 μmol/L
34 (0.7) 28 (82%) Renal replacement therapy
Chrysopoulo, et al. [16] 1999 1981–1998; 1,404 patients, 
TBSA% >30%
76 (5.4%) 67 (88%) Three of these four: oliguria (<350 mL/36 hours), 
BUN/creatinine ratio <20, serum creatinine >177 
μmol/L, and dialysis
67 (4.8%) 61 (91%) Renal replacement therapy
Kim, et al. [17] 2003 2000; 147 patients, 60% 
TBSA%
28 (19%) 28 (100%) Serum creatinine >177 μmol/L
3 (2.0%) 3 (100%) Renal replacement therapy
Mustonen and Vuola 
[22]
2008 1988–2001; 238 patients, 
31% TBSA%
93 (39.1%) 41 (44%) Serum creatinine >120 μmol/L
32 (13%) 20 (62%) Renal replacement therapy
Cumming, et al. [6] 2001 1998–1999; 85 patients, 30% 
TBSA%
3 (3.5%) MODS (3–4: serum creatinine >350 μmol/L)
Cooper, et al. [18] 2006 1999–2001; 42 patients, 35% 
TBSA%
3 (7.1%) MODS (3–4: serum creatinine >350 μmol/L) or 
oliguria
Coca, et al. [19] 2007 1998–2003; 304 patients, 
27% TBSA%
81 (27%) 23 (28%) RIFLE
(73%) Renal replacement therapy
Lopes, et al. [20] 2007 2004–2006; 126 patients, 
24% TBSA%
45 (36%) 21 (47%) RIFLE
11 (8.7%) Renal replacement therapy
The table shows number of patients who had acute kidney injury (AKI) according to the criteria in the rightmost column; the percentage is the 
incidence of AKI among the study population. AKI mortality is the number of patients who died among those with AKI, with the percentage referring 
to mortality among the AKI patients. When available, incidence and outcome of renal replacement therapy are shown in the table, together with the 
result from the primary AKI criteria. Percentage burned of total body surface area (TBSA%) is the mean of the study group. When a TBSA% limit for 
inclusion was reported instead, it is shown in this table as 'TBSA% >%'. BUN, blood urea nitrogen; MODS, Multiple Organ Dysfunction Score; 
RIFLE, the increasing severity classes Risk, Injury, and Failure and the two outcome classes Loss, and End-stage renal disease.Available online http://ccforum.com/content/12/5/R124
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classification (Table 1). Another shortcoming was that most
studies were carried out retrospectively. Of the studies that
claimed to collect data prospectively, not all measures of
organ failure were collected according to a true prospective
protocol [6,7]. It is therefore obvious that there is a risk that
organ dysfunction may have been overlooked or missed. The
mortality among burned patients who developed AKI was
between 28% and 100% and was 50% to 100% among
those who were treated with renal replacement therapy. The
reported incidence of renal replacement therapy varied from
0.7% to 14.6% (Table 1) [6-22].
It is evident therefore that the definitions, protocols, and col-
lection of data vary considerably among different studies,
which makes it difficult to compare results. For the present
investigation, we chose to use the RIFLE (Risk, Injury, Failure,
Loss of kidney function, and End-stage kidney disease) classi-
fication, which was developed recently by the Acute Dialysis
Quality Initiative Group and published as a consensus defini-
tion of acute renal failure in critical care [23]. We set up the
following hypotheses about the present study: first, AKI is
common and develops soon after a major burn. Second, it is
affected by factors that are described as important for the
development of multiple organ dysfunction or failure in patients
with burns such as age [6,7,24], percentage burned of total
body surface area (TBSA%) [6,7,24], and sepsis
[11,12,15,16,19]. As AKI develops together with failure of
other organs [7,11,14] and outcome depends on the number
and degree of failing organs [6,7,24], assessment of organ
failures was made in parallel with the sequential organ failure
assessment (SOFA) [25], which is well documented and vali-
dated [26-28].
Materials and methods
The burn centre serves 3.3 million inhabitants for referral of
patients who require specialist burn care (major burns) from
the southern part of Sweden. Consecutive patients with a
TBSA% of 20% or more, who were admitted between 1997
and 2005 (8.5 years), were studied. Clinical and laboratory
data, collected according to a preset protocol, were recorded
during the study period. Patients who died within the first 2
days, including those from whom treatment was withheld or
withdrawn early, were excluded. Patients with superficial
burns that did not require operation and whose time in hospital
was short (1 to 7 days) were also excluded (Figure 1). The
local ethics committee at Linköping University Hospital waived
the need for their approval for descriptive and explorative stud-
ies that do not include any procedures that are not considered
as ordinary burn care.
Treatment of burns and supportive intensive care
Ringer's acetate was used for fluid resuscitation in volumes
according to the Parkland formula (4 mL/kg body weight
[BW]/TBSA%) [29-31], with adjustments for individual varia-
tions in hemodynamic variables, aiming at least for a mean
arterial pressure of 70 mm Hg and a urine output of 1 mL/kg
BW per hour. When fluid volume substitution alone was insuf-
ficient to maintain central hemodynamics, adrenergic drugs
(dobutamine and norepinephrine) were used. Renal replace-
ment therapy was considered when the plasma creatinine con-
centration exceeded 300 μmol/L, together with oliguria or
anuria.
Excision and grafting operations were done within 24 to 48
hours. Patients who did not seem to have deep burns at pri-
mary examination were re-evaluated daily and operated on if
full thickness burns (FTBs) were identified. Wounds were cov-
ered by autologous grafts when available or, in extensive
burns, either by heterologous grafts for temporary cover or (in
special cases) by cultured keratinocytes. Operations were
repeated when donor sites again became available. Silver sul-
fadiazine (Flamazine®; Smith & Nephew, Hull, UK) was applied
to both grafted and non-grafted wounds. Infection control was
managed in collaboration with the university hospital infection
specialists.
Ventilation was pressure-controlled (Siemens 900 C or Sie-
mens 300 A; Siemens, Solna, Sweden) with tidal volumes of
6 to 8 mL/kg BW, a positive end-expiratory pressure of at least
5 cm H2O, and aiming at low ventilatory plateau pressures (of
less than 35 cm H2O) [32]. Nutrition was provided enterally
from day 1, pain was controlled by continuous infusions of opi-
oids, and sedation was carried out by infusion of
benzodiazepines.
Classification of acute kidney injury
AKI was classified by a dynamic classification scheme with
three levels for acute renal dysfunction: Risk, Injury, and Failure
and two clinical outcomes, Loss of kidney function and End-
stage kidney disease (RIFLE) [23]. It is based on how the
Figure 1
Algorithm showing selection of patients Algorithm showing selection of patients. TBSA, percentage burned of 
total body surface area.Critical Care    Vol 12 No 5    Steinvall et al.
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plasma creatinine concentration is increased compared with
the baseline value of the individual patient, reduced urinary
output, and the need for renal replacement therapy. The earli-
est available plasma creatinine concentration measurement
was used as the baseline. Plasma creatinine concentrations
from the first week, and thereafter the highest value weekly,
were used for RIFLE classification and assessment of renal
recovery.
Classification of organ dysfunction
SOFA score was recorded at admission and at least three
times a week. SOFA score is based on the assessment of six
organ dimensions: (a) renal: plasma creatinine concentration
or urine output, (b) respiratory: arterial partial pressure of oxy-
gen/fraction of inspired oxygen (PaO2/FiO2) ratio, (c) cardio-
vascular: hypotension or need for adrenergic agents, (d)
coagulation: platelet count, and (e) hepatic: plasma bilirubin
concentration. The neurological part of SOFA (f) was left out
because of the difficulties in assessing the Glasgow coma
score in sedated patients. Maximum SOFA is the maximum
score value from each organ score, regardless of date [27].
For this study, multiple organ failure was defined as 3 to 4
score points in two or more organ dimensions of the SOFA
score [26]. Blood samples were drawn at the time of admis-
sion and at least three times a week in accordance with the
Burn Unit protocol for major burns. Admission values were
used to compare baseline values among groups; the worst
value of each patient during the first week was used to analyse
factors of importance for AKI. The worst overall value was
used to analyse factors of importance for mortality, and the
worst value of each patient each week was used to calculate
the maximum SOFA score and the descriptive figures of the
time course. Laboratory variables were analysed by routine
methods and data were stored in the countywide database of
the laboratory. Sepsis and systemic inflammatory response
syndrome (SIRS) were classified according to the American
College of Chest Physicians/Society of Critical Care Medicine
Consensus Conference [33].
Additional data acquisition
All patients were recorded prospectively in the Linköping Burn
Unit Database. At admission, extent (TBSA%) and depth
(FTB%) of injury were recorded together with patient charac-
teristics such as age and gender [34]. Daily recordings of care
and treatment included variables such as requirement for dial-
ysis, mechanical ventilation, and adrenergic agents. Data
regarding the giving of nephrotoxic antibiotics (vancomycin,
aminoglycosides, and amphotericin B) and exposure to intra-
venous contrast (computed tomography [CT] scans) were
extracted from medication charts.
Statistics
Data were analysed with STATISTICA 7 (StatSoft, Inc., Tulsa,
OK, USA) and presented as mean and 95% confidence inter-
val (CI). The differences in baseline characteristics and out-
come among patients with and without AKI and the
differences in mean values between those who developed AKI
early and late were analysed using Student t test for continu-
ous data and contingency tables with Pearson chi-square test
for categorical variables. Analysis of covariance was used
adjusting laboratory data for age and TBSA%. The Tukey une-
qual N HSD (honest significant difference test for unequal
sample sizes) was used as a post hoc test. The difference in
progress time was analysed by using Student t  test for
dependent samples. One-way analysis of variance, for contin-
uous data, and contingency tables with Pearson chi-square
test for categorical variables were used to analyse the differ-
ences in baseline characteristics and outcome among the
patients who developed AKI, grouped in RIFLE classes. Con-
tinuous variables were arbitrarily categorised when exploring
risk factors for the development of early and late AKI with odds
ratios: cutoff age of 60 years, FTB% of 25%, TBSA% of 50%,
and reaching the level for Risk within the first 7 days for early
AKI.
Results
Incidence
The incidence of AKI among major burns was 0.11 per
100,000 people per year during the study period. (See selec-
tion of patients in Figure 1.) For the majority (14 of 17) of the
excluded patients who died within 2 days, active burn care
was withheld or withdrawn because of extensive and deep
burns, and 8 of the 14 patients were more than 70 years old.
They were older (71.1 years, 95% CI 63.8 to 78.5) and had
more extensive burns (58.6% TBSA%, 95% CI 46.4% to
70.8%) than the 127 patients in the study group (P <0.001).
Three patients had renal failure before active treatment was
withdrawn, but no renal replacement therapy was started.
Eight patients with superficial burns (25.1% TBSA%, 95% CI
20.3% to 29.9%) that did not require operation and who were
inpatients for only a short period (5.3 days, 95% CI 0.68 to
9.82) were also excluded.
A total of 127 patients remained in this study (Table 2), of
whom 24% developed AKI (11.8% Risk, 7.9% Injury, and
4.7% Failure) and 3% required renal replacement therapy
(Table 3). Overall mortality was 14%. Twenty-nine of the 31
patients who developed AKI had flame burns. One of the two
remaining patients had an electrical burn, and one had a chem-
ical hot scald burn (industrial); both were classified as Risk.
Seven of the 31 patients (1 classified as Risk, 2 as Injury, and
4 as Failure) had previous histories of hypertension, but none
had a documented history of renal dysfunction. One of the
patients who was classified as Risk had a previous history of
taking lithium. No others had histories of diagnoses affecting
the kidney before the burn.
Half of the patients who developed AKI (55%, 17 of 31)
reached the level for Risk within the first 7 days, and 81% (25
of 31) within 14 days. The progress time from Risk to maxi-Available online http://ccforum.com/content/12/5/R124
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Table 2
Characteristics, baseline, and outcome of patients studied who were classified by RIFLE
No AKI (n = 96) AKI (n = 31) P value Adjusted
Age, years 35.9 (31.8 to 40.1) 55.1 (47.4 to 62.7) <0.001
Total body surface area, percentage burned 35.8 (33.0 to 38.5) 47.2 (38.3 to 56.1) 0.001
Full thickness burns, percentage 13.6 (10.9 to 16.4) 32.0 (24.0 to 40.0) <0.001
Gender, female/male 22/74 10/21 0.30
Mortality 7 (7.3%) 11 (35.5%) <0.001
Multiple organ failure 3 (3.1%) 24 (77.4%) <0.001
Mechanical ventilation 51 (53.1%) 30 (96.8%) <0.001
Length of stay for survivors, days 39.9 (32.5 to 47.3) 67.3 (46.0 to 88.6) 0.004
Baseline laboratory variables
Plasma creatinine, μmol/L 81.3 (76.4 to 86.1) 82.3 (72.0 to 92.5) 0.85 0.87
Platelet count, × 109/L 238 (218 to 259) 278 (231 to 326) 0.08 0.14
Plasma bilirubin, μmol/L 18.9 (15.5 to 22.3) 24.0 (17.3 to 30.6) 0.13 0.21
Worst laboratory value during the first week
Lowest platelet count, × 109/L 120 (106 to 133) 68 (48 to 87) <0.001 0.001
Plasma bilirubin, μmol/L 19.9 (16.7 to 23.0) 37.4 (26.1 to 48.6) <0.001 0.001
Data are mean (95% confidence interval) or number (percentage). Acute kidney injury (AKI) is classified by RIFLE (Risk, Injury, Failure, Loss of 
kidney function, and End-stage kidney disease). Multiple organ failure is 3 to 4 sequential organ failure assessment score points in more than one 
organ dimension. Worst laboratory value is the highest value for bilirubin and the lowest value for platelet count. We used contingency table 
Pearson chi-square test for categorical variables, Student t test for continuous data, and analysis of covariance (with P value from post hoc 
analysis between AKI and no AKI) to adjust for age and for percentage burned of total body surface area.
Table 3
Characteristics, baseline, and outcome of the patients who developed acute kidney injury classified by RIFLE (n = 31)
Risk (n = 15) Injury (n = 10) Failure (n = 6) P value
Age, years 47.7 (36.1 to 59.2) 56.9 (42.7 to 71.1) 70.5 (55.1 to 85.9) 0.07
Total body surface area, percentage burned 45.6 (32.5 to 58.7) 56.5 (37.1 to 75.9) 35.8 (17.8 to 53.9) 0.25
Full thickness burns, percentage 32.4 (19.9 to 44.8) 36.0 (17.2 to 54.9) 24.3 (14.4 to 34.3) 0.60
Gender, female/male 6/9 2/8 2/4 0.58
Mortality 2 4 5 0.01
Dialysis - - 4
Recovery 13 5a 2b 0.04
Multiple organ failure 9 9 6 0.07
Lowest mean arterial pressure, mm Hg 56.0 (53.2 to 58.8) 62.2 (56.1 to 68.3) 57.2 (52.4 to 61.9) 0.06
Adrenergic drugs on days 1–3c 11 5 5 0.31
Mechanical ventilation 15 9 6 0.34d
Length of stay for survivors, days 69.2 (40.0 to 98.3) 66.8 (17.2 to 116.4) 46 0.90
Data are mean (95% confidence interval) or number of patients. Acute kidney injury is classified by RIFLE (Risk, Injury, Failure, Loss of kidney 
function, and End-stage kidney disease). Multiple organ failure is 3 to 4 sequential organ failure assessment score points in more than one organ 
dimension. The lowest recorded mean arterial pressure from days 1 to 3 was used. aOne patient was transferred to another hospital before 
recovery. bThe patient who survived Failure was partially normalised after 7 weeks, and one patient whose recovery was complete after 9 weeks 
died after 16 weeks. cNumber of patients who required adrenergic drugs during days 1 to 3. We used contingency table Pearson chi-square test 
for categorical variables (dthree of the six expected values were less than 1) and one-way analysis of variance for continuous data.Critical Care    Vol 12 No 5    Steinvall et al.
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mum RIFLE class was 5.2 days (95% CI 2.0 to 8.5) among the
16 patients who reached Injury and Failure, whereas the time
from baseline to Risk was 9.4 days (95% CI 5.9 to 13.0) (P =
0.095). Early AKI was arbitrarily defined as when creatinine
reached the level for Risk within the first 7 days, late AKI
between days 8 and 60 (Table 4). We found a more than two-
fold higher risk for younger patients (risk ratio 2.35) and for
patients with extensive deep burns (risk ratio 2.25) to develop
AKI early (Table 5).
Recovery and mortality
Renal function recovered completely during the time of admis-
sion to the burn unit among all patients who survived except
for two: the dialysed patient who survived, whose renal func-
tion partially recovered, and one patient classified as Injury,
who was transferred to another hospital before recovery. Mor-
tality increased with increasing AKI class. The 11 patients hav-
ing AKI and who died all had multiple organ failure. Among the
four patients who required renal replacement therapy, plasma
creatinine was within the reference range during the first day
after injury in all cases but one, whose plasma creatinine was
126 μmol/L. All four had multiple organ failure before dialysis,
and two had sepsis before. The remaining two already had
SIRS on admission but no sepsis during their stay. The treat-
ment with dialysis started on days 5 to 19 (10 to 15 days of
treatment over 13 to 21 days), and the week-maximum plasma
creatinine concentration and plasma urea before starting were
392.0 μmol/L (208.5 to 575.5) and 28.9 mmol/L (15.2 to
42.7), respectively. Two of the patients were oliguric the day
before, and the patient with early dialysis (day 5) was oliguric
4 days before. Three of the dialysed patients died.
Factors of importance in the development of acute 
kidney injury
Predisposing factors
Age, TBSA%, and extent of FTBs were greater among the
patients who developed AKI (Table 2). We found no signifi-
cant difference in these variables between the RIFLE classes
when we analysed the AKI-classified patients, even if there
was a trend toward increasing age (Table 3).
Sepsis
The patients who developed AKI (n = 31) all fulfilled the crite-
ria for SIRS on day 1, and 87% (27 of 31) developed sepsis,
of whom 19 were classified as severe sepsis or septic shock.
Sepsis developed within a week before the first sign of renal
dysfunction (reaching the level of Risk) in 48%, and most of
these records of sepsis were classified as severe. Sepsis
cumulative onset is presented in Figure 2. Sepsis also devel-
oped without inducing further renal dysfunction during the
renal recovery period among seven patients.
Potentially nephrotoxic exposures
Twelve of the AKI-classified patients (39%) were treated with
potentially nephrotoxic antibiotics and five of them required
more than one. The total number of treatment periods among
them was 25. In 6 of the 12 patients, an increase in the plasma
creatinine concentration was seen after starting one treatment
(starting day ranged from 3 to 92 after the burn) and severe
sepsis was present on all of these occasions.
Seven of the patients who did not develop AKI were exposed
to intravenous contrast (CT scans). One of the patients who
were classified as Failure was exposed on day 2 in parallel
with increasing plasma creatinine concentration, and 2
patients classified as Risk were exposed 6 and 19 days,
Table 4
Early and late acute kidney injury: characteristics, multiple organ failure, and sepsis
Early AKI (n = 17) Late AKI (n = 14) P value
Age, years 48.9 (39.7 to 58.1) 62.6 (49.7 to 75.5) 0.07
Total body surface area, percentage burned 53.3 (41.0 to 65.6) 39.8 (26.4 to 53.2) 0.13
Full thickness burns, percentage 39.4 (28.1 to 50.7) 23.0 (12.2 to 33.8) 0.04
Multiple organ failure 14 10 0.47
Sepsis 15 12 0.83
Lowest value of MAP for days 1–3, mm Hg 57.5 (54.9 to 60.2) 59.1 (54.3 to 63.9) 0.53
Plasma myoglobin for days 1–2, μg/L 1,167 (-484 to 2,820) 220 (103 to 337) 0.24
Mechanical ventilation 17 13 -
Length of stay, days 45.7 (27.8 to 63.6) 60.6 (27.9 to 93.4) 0.37
Data are mean (95% confidence interval) or number of patients. Early acute kidney injury (AKI) is defined as when creatinine reached the level for 
Risk within the first 7 days; late AKI occurred between days 8 and 60. Multiple organ failure is defined as 3 to 4 score points in two or more organ 
dimensions of the sequential organ failure assessment score. (Contingency table, Pearson chi-square test for categorical variables, and Student t 
test for continuous data.) MAP, mean arterial pressure.Available online http://ccforum.com/content/12/5/R124
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respectively, before the increase. Plasma myoglobin (highest
value days 1 to 2) values were 1,606 μg/L (95% CI 677 to
2,534) in the non-AKI group and 712 μg/L (95% CI -111 to
1,537) among the patients who developed AKI (P = 0.22).
Relation to other organs
Organ dysfunction in general was most pronounced during
the first weeks after injury (Figure 3), and outcome depended
on the number and degree of failing organs. Maximum SOFA
total was 14.1 (95% CI 12.5 to 15.6) among non-survivors
with AKI compared with 10.2 (95% CI 9.0 to 11.4) among sur-
vivors with AKI (P <0.001, adjusted for age and TBSA% P =
0.001). But when each dimension was analysed among the 31
patients with AKI, only the renal and cardiovascular dimen-
sions were higher among the patients who died (maximum
renal dimension was 2.7 (95% CI 1.9 to 3.6) and the cardio-
vascular dimension was 3.6 (95% CI 3.3 to 4.0) among non-
survivors compared with 1.2 (95% CI 0.7 to 1.6) and 2.4
(95% CI 2.1 to 2.7) among survivors (P  <0.001 for both
dimensions, adjusted for age and TBSA% P = 0.002 for renal
dimension, and P <0.001 for cardiovascular dimension)). Pul-
monary dysfunction preceded AKI, and 97% (30 of 31)
required mechanical ventilation and 61% (19 of 31) had a
PaO2/FiO2 ratio reduced to less than 200 mm Hg (scoring 3 to
4 points on the SOFA respiratory dimension) within the first 3
days.
Discussion
This is, to our knowledge, the first study to assess AKI in burns
using a prospective protocol with the RIFLE classification as
well as the assessment of organ failure, SIRS, and sepsis
using conventional criteria and definitions. The study adds
new and important information about several topics in a com-
Table 5
Early and late acute kidney injury: odds ratio for characteristics, multiple organ failure, and sepsis
Early AKI Late AKI
Failure/Injury/Risk (all patients) 3/5/9 (17) 3/5/6 (14) 95% CI OR
Age of <60/≥60 years 13/4 5/9 1.22 to 28.0 5.85
TBSA% of ≥50%/<50% 10/7 3/11 1.06 to 26.0 5.20
FTB% of ≥25%/<25% 12/5 4/10 1.26 to 28.5 6.00
Gender, male/female 12/5 9/5 0.29 to 6.04 1.33
Mortality (non-survivors) 6 5 0.22 to 4.30 0.98
Dialysis 3 1 0.26 to 30.27 2.79
MOF before AKI 13 10 0.26 to 6.52 1.30
Sepsis before AKI 11 8a 0.32 to 5.88 1.38
MOF and sepsis both before AKI 8 8 0.16 to 2.77 0.67
MAP episode <60 mm Hg on days 1–3 10 9 0.18 to 3.41 0.79
Adrenergic drugs on days 1–3 14 7 0.91 to 23.79 4.67
Data are number of patients. Early acute kidney injury (AKI) is defined as when creatinine reached the level for Risk within the first 7 days; late AKI 
occurred between days 8 and 60. Multiple organ failure (MOF) is defined as 3 to 4 score points in two or more organ dimensions of the sequential 
organ failure assessment score. Onset on the same day as AKI is included in the onset before category. aTwo more patients had sepsis before 
AKI, but there were 11 and 48 days, respectively, between their sepsis recordings and AKI onset, which was on days 25 and 60. Continuous 
variables were arbitrarily categorised: cutoff for age was 60 years, full thickness burn percentage (FTB%) was 25%, and percentage burned of 
total body surface area (TBSA%) was 50%. CI, confidence interval; MAP, mean arterial pressure; OR, odds ratio.
Figure 2
Day of onset of renal dysfunction, respiratory dysfunction, and sepsis Day of onset of renal dysfunction, respiratory dysfunction, and sepsis. 
Cumulative percentage of the patients who developed renal dysfunc-
tion showing when their plasma creatinine concentration exceeded at 
least 1.5 × baseline (n = 31, thick line) and who developed severe res-
piratory dysfunction (sequential organ failure assessment score of 3 to 
4 = PaO2/FiO2 [arterial partial pressure of oxygen/fraction of inspired 
oxygen] below 200 mm Hg, n = 28, thin line) and sepsis (n = 27, dot-
ted line). X-axis shows the first 14 days after injury. The remaining times 
are weeks.Critical Care    Vol 12 No 5    Steinvall et al.
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prehensive way. It shows that AKI is common, that AKI corre-
sponds to about a quarter of those with a TBSA% of more
than 20%, and that survivors can recover from AKI. AKI also
develops soon after injury and is closely paralleled by dysfunc-
tion of other organs. We found that AKI was preceded by lung
dysfunction in almost all of the cases, as has previously been
claimed by Sheridan and colleagues [14]. Only the cardiovas-
cular dysfunction (maximum SOFA) and AKI were associated
with mortality. The relation with sepsis was not as incontesta-
ble as is usually claimed since sepsis was not always followed
by renal dysfunction.
Renal dysfunction seems to follow a course similar to that of
other dysfunctioning or failing organs, more so as the time
delay between different organ dysfunctions can be considered
(at least to some extent) as being marker-specific rather than
organ-specific. The actual impact on the kidneys is likely to
happen before the increase in plasma creatinine concentration
is detected. For example, Kang and colleagues [35] found
raised 24-hour urinary N-acetyl-beta-D-glucosaminidase activ-
ity (a marker of proximal tubular dysfunction or damage) on day
1 among the 12 burned patients whom they studied (30%
TBSA%). It was almost doubled on day 1, continued to
increase, and peaked on day 7.
Incidence and occurrence
We found AKI to be common, with an incidence of about a
quarter of major burns, which is similar to that reported in a
recent paper by Coca and colleagues [19] and slightly less
than reported in a letter from Lopes and colleagues [20].
Median time to reaching respective RIFLE class was 10 days
in our AKI group, which is the same as that reported by Lopes
and colleagues [20]. However, unlike Coca and colleagues
[19], we did not find a difference in the time of occurrence
between RIFLE classes. The requirement of renal replacement
therapy among patients with burns who require intensive care
seems not to differ from that of general intensive care units
(ICUs). The percentage of renal replacement therapy in our
study (3.1%) is close to that reported in ICU patients (Hoste
and colleagues [2] 4.1%, Bell and colleagues [36] 2.5%, Uch-
ino and colleagues [4] 4.3%, and Dalfino and colleagues [37]
8.1%) and in most studies of patients with burns (Table 1).
Recovery or mortality
All of the surviving patients in the present study recovered
renal function (defined according to RIFLE). This is consistent
with findings reported by several others [8,10,12,15]. In a mul-
ticentre long-term follow-up of patients in intensive care who
had required renal replacement while they were in hospital,
3.4% (34 of 998) of those who survived developed late end-
stage kidney disease, as identified from a nationwide register
for chronic renal disease [38].
Mortality increased with increasing RIFLE class, and in the
studies of Coca and colleagues [19] and Lopes and col-
leagues [20] mortality rates were 60% and 75%, respectively,
in the Failure class, whereas the rate was 5 of 6 in our study.
Overall mortality rates were 14% in our study, 13% in the
study of Coca and colleagues, and 18% in the study of Lopes
and colleagues. ICU mortality among RIFLE-Failure-classified
patients seems to be somewhat lower than among burned
patients who were classified as Failure. Hoste and colleagues
[2] reported 26% mortality in the Failure class from a study of
critically ill patients, and Lopes and colleagues [39] found a
55% mortality in the Failure class among patients with sepsis.
Pathophysiology of renal dysfunction in burns
The reason for AKI among patients with major burns may be
multifactorial. We found that the acute increase in plasma cre-
atinine concentration was preceded by the initial inflammatory
response (SIRS) and pulmonary dysfunction. Pulmonary dys-
function after trauma has been suggested to promote patho-
genic inflammation and the development of multiple organ
failure, including renal failure [40]. In our recent study of acute
respiratory dysfunction in patients with major burns, we noted
that acute respiratory distress syndrome occurs soon after the
burn – usually within 3 days – and that renal dysfunction was
more common among the patients with the most severe respi-
ratory dysfunction [32]. This, together with the early onset of
organ dysfunction, including renal dysfunction, suggests that
it is the burn and resuscitation rather than infective complica-
tions that are responsible for the failing organs.
Figure 3
Maximum sequential organ failure assessment (SOFA) score among  the patients who developed renal dysfunction (n = 31) Maximum sequential organ failure assessment (SOFA) score among 
the patients who developed renal dysfunction (n = 31). SOFA score is 
calculated on the maximum value for each of five organ dimensions 
weekly during the first 7 weeks after injury: maximum SOFA respiratory 
dimension (closed square, open box), cardiovascular dimension (open 
square, shaded box), coagulation dimension (closed square, diagonal 
pattern in the box), renal dimension (open square, closed box), and 
hepatic dimension (open square, open box). Squares indicate the 
mean, the box indicates standard error, and whiskers indicate 95% 
confidence interval.Available online http://ccforum.com/content/12/5/R124
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Sepsis
Sepsis occurred in 87% of the AKI group, which is of the same
magnitude as reported in previous burn studies [11,19]. We
found that severe sepsis was associated with AKI, even if not
all episodes of severe sepsis caused renal dysfunction. In four
of six cases in which AKI was of latest onset (days 18 to 60
after burn), it was not preceded by sepsis, contradicting the
idea that AKI of late onset was associated mainly with sepsis
[15,17]. Chrysopoulo and colleagues [16] found that AKI
among survivors was not the result of sepsis since it preceded
sepsis in their study. Another interesting finding is that we
found sepsis during the renal recovery period without inducing
further renal dysfunction, which has not been previously
reported. This finding indicates that at least some of the time-
associated episodes of sepsis and renal dysfunction may also
be just time-related rather than the result of cause and effect
– a possibility that is usually not discussed in studies of burned
patients where AKI is considered to be strongly associated
with sepsis [10,12,15,17,19].
Predisposing factors
We found age, TBSA%, and FTB% to be predisposing factors
for AKI but were unable to show the corresponding relation for
severity of AKI, most probably because of a lack of power.
Coca and colleagues [19] also found older patients in the AKI
group, whereas others (for example, Holm and colleagues [11]
and Kim and colleagues [17]) found a higher TBSA% in the
AKI group, but not advanced age. In the study by Kim and col-
leagues, mean TBSA% was unusually high in the AKI group
(80%) whereas age was relatively young (42 years).
Method
It is important to evaluate the characteristics of patients with
burns. Effects are seen on incidence of organ dysfunction and
on outcome by the number of patients who have treatment
withheld or withdrawn. In different studies, the size of this
group has been in the range of 5% to 11% [6,14]. In a number
of studies, no such data are presented [8-13,15-17,19-21].
We have excluded all patients who died within the first 48
hours, including cases of initial withholding or withdrawal of
treatment. The exclusion criteria of 'short hospital stay' has
been used by others [7].
The potential selection bias from excluding the patients with
the worst (death within 2 days) and the best (short duration of
stay) outcomes has probably influenced the incidence of AKI
in this study. The finding that young age is a risk factor for early
AKI can also be explained by this selection bias since older
patients with extensive burns more often have a lethal
outcome.
The fluid resuscitation early after burn is a problem when using
the RIFLE criteria and not having a true baseline plasma creat-
inine concentration taken. The initially low concentrations in
plasma, however, should be of the same magnitude among
burn patients as a group, reflecting a physiological response
to the burn and the fluid resuscitation. Hence, using the RIFLE
classification may still be reliable for comparing incidences of
acute renal dysfunction between studies of burn patients. The
same 'misclassification' problem is, however, likely to occur
among other patient groups who are subjected to aggressive
fluid resuscitation (ICU patients with major trauma or those
with severe sepsis) and whose true baseline may be unknown.
Whether the RIFLE should be modified for these circum-
stances needs to be further examined.
Conclusion
AKI is common, develops soon after the burn, and is paralleled
by multiple organ dysfunction or failure, which also appear
early. Among the dysfunctioning organs, cardiovascular dys-
function (SOFA) together with AKI was associated with a
higher mortality. The prognosis for minor dysfunction remains
good and survivors recover from AKI, whereas renal failure still
carries a high mortality. Pulmonary dysfunction preceded AKI
and 30 of the 31 patients with AKI required mechanical venti-
lation whereas only half of those with no AKI required mechan-
ical ventilation. Sepsis was not always followed by AKI.
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